Programmed Cell Death Ligand 1 Expression in Cytological and Surgical Non–Small Cell Lung Cancer Specimens in Association with EGFR Mutation and Overall Survival: A Single-Institution Experience

Elif SAYMAN GOKAL; Fugen VARDAR AKER; Zuhal KUS SILAV; Bala Basak OVEN

doi:10.5146/tjpath.2022.01572

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE)

Table of Contents

2022, Volume 38, Number 3, Page(s) 261-274

[ Abstract (English) ] [ Full Text (English) ] [ PDF ]

DOI: 10.5146/tjpath.2022.01572

Programmed Cell Death Ligand 1 Expression in Cytological and Surgical Non–Small Cell Lung Cancer Specimens in Association with EGFR Mutation and Overall Survival: A Single-Institution Experience

Elif SAYMAN GOKAL¹, Fugen VARDAR AKER², Zuhal KUS SILAV², Bala Basak OVEN³

¹Department of Pathology, Inonu University, Faculty of Medicine, MALATYA, TURKEY
²University of Health Sciences, Haydarpasa Numune Training and Research Hospital, ISTANBUL, TURKEY
³Department of Medical Oncology, BAU Medical Park Göztepe Hospital, ISTANBUL, TURKEY

[ Abstract (English) ] [ PDF ]